BACE1 and Alzheimer disease: For example, NRF2 represses the expression of β‐site APP‐cleaving enzyme (BACE1) and BACE1‐mRNA‐stabilizing antisense RNA by binding to AREs in their promoters, consequently preventing the Aβ pathogenic process in AD.36